Media 06 Sep 2024 The Australian | Orthocell’s collagen-membrane dental-regeneration product Striate+ debuts in Canada Orthocell's entry to to the Canadian market with the first sales of Striate+ has been reported in The Australian in… Orthocell
Media 24 Jul 2024 Proactive | Interview with Paul Anderson Following the announcement that Orthocell is accelerating its global market expansion of Striate+™ and Remplir™, Managing Director Paul Anderson spoke… Orthocell
Media 10 Jul 2024 The Australian Business Review | Investors are all ears as Orthocell’s nerve and tissue solutions deliver record revenue News of Orthocell's record-breaking quarterly and full year revenue has been published in a Special Report in The Australian Business… Orthocell
Media 10 Jul 2024 Business News | Orthocell posts record revenue Orthocell's record revenue for FY24 has been reported in Business News. Orthocell
Media 10 Jul 2024 Proactive Interview | Record-breaking revenue for FY24 Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to discuss the Company's record-breaking revenue for the June… Orthocell
Company News, Media 14 Jun 2024 Petra Capital Research Report | June 2024 Petra Capital has released research report, forecasting Orthocell’s potential to reach A$1.28 per share. Orthocell
Media 26 Mar 2024 Proactive Interview with Paul Anderson Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to provide an update on the Company's market authorisation… Orthocell
Media, Video 23 Feb 2024 Proactive | Interview with CEO Paul Anderson Orthocell CEO Paul Anderson spoke with Proactive about the Company’s recent strategic placement of $3.5 million, adding prominent investors to… Orthocell
Media 22 Feb 2024 The West Australian | Chris Ellison, Rod Jones and the McCuskers jump into Orthocell Orthocell’s Company-led strategic placement has been reported in The West Australian newspaper, in an article by Senior Business Report Sean… Orthocell
Media, Video 22 Nov 2023 ABC News | Tennis elbow treatment trial successes offer hope for sufferers wary of surgery Orthocell recently released compelling new data from our clinical trial comparing the effectiveness of our tendon cell therapy (OrthoATI™) to… Orthocell
